BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11238278)

  • 1. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.
    Shah AS; White DC; Emani S; Kypson AP; Lilly RE; Wilson K; Glower DD; Lefkowitz RJ; Koch WJ
    Circulation; 2001 Mar; 103(9):1311-6. PubMed ID: 11238278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute ischemic cardiac dysfunction is attenuated via gene transfer of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARK1).
    Tevaearai HT; Walton GB; Keys JR; Koch WJ; Eckhart AD
    J Gene Med; 2005 Sep; 7(9):1172-7. PubMed ID: 15880449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor.
    Tevaearai HT; Eckhart AD; Shotwell KF; Wilson K; Koch WJ
    Circulation; 2001 Oct; 104(17):2069-74. PubMed ID: 11673348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor heart contractile dysfunction following prolonged ex vivo preservation can be prevented by gene-mediated beta-adrenergic signaling modulation.
    Tevaearai HT; Walton GB; Eckhart AD; Keys JR; Koch WJ
    Eur J Cardiothorac Surg; 2002 Nov; 22(5):733-7. PubMed ID: 12414039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a beta-adrenergic receptor kinase inhibitor reverses dysfunction in failing cardiomyocytes.
    Eckhart AD; Koch WJ
    Mol Ther; 2002 Jan; 5(1):74-9. PubMed ID: 11786048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.
    White DC; Hata JA; Shah AS; Glower DD; Lefkowitz RJ; Koch WJ
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5428-33. PubMed ID: 10779554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.
    Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ
    Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Level of beta-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure.
    Tachibana H; Naga Prasad SV; Lefkowitz RJ; Koch WJ; Rockman HA
    Circulation; 2005 Feb; 111(5):591-7. PubMed ID: 15668342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. betaARK1 inhibition improves survival in a mouse model of heart failure induced by myocardial infarction.
    Suzuki Y; Nakano K; Sugiyama M; Imagawa J
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):329-34. PubMed ID: 15475830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes.
    Drazner MH; Peppel KC; Dyer S; Grant AO; Koch WJ; Lefkowitz RJ
    J Clin Invest; 1997 Jan; 99(2):288-96. PubMed ID: 9005997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of two Gbetagamma-binding proteins--N-terminally truncated phosducin and beta-adrenergic receptor kinase C terminus (betaARKct)--in heart failure.
    Li Z; Laugwitz KL; Pinkernell K; Pragst I; Baumgartner C; Hoffmann E; Rosport K; Münch G; Moretti A; Humrich J; Lohse MJ; Ungerer M
    Gene Ther; 2003 Aug; 10(16):1354-61. PubMed ID: 12883532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.
    Raake PW; Schlegel P; Ksienzyk J; Reinkober J; Barthelmes J; Schinkel S; Pleger S; Mier W; Haberkorn U; Koch WJ; Katus HA; Most P; Müller OJ
    Eur Heart J; 2013 May; 34(19):1437-47. PubMed ID: 22261894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer.
    Akhter SA; Skaer CA; Kypson AP; McDonald PH; Peppel KC; Glower DD; Lefkowitz RJ; Koch WJ
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12100-5. PubMed ID: 9342369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance.
    Shah AS; Lilly RE; Kypson AP; Tai O; Hata JA; Pippen A; Silvestry SC; Lefkowitz RJ; Glower DD; Koch WJ
    Circulation; 2000 Feb; 101(4):408-14. PubMed ID: 10653833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.
    Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ
    Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice.
    Rockman HA; Chien KR; Choi DJ; Iaccarino G; Hunter JJ; Ross J; Lefkowitz RJ; Koch WJ
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7000-5. PubMed ID: 9618528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular beneficial effects of beta adrenergic receptor kinase inhibitor (betaARKct) gene transfer in a rat model of severe pressure overload.
    Molina EJ; Gupta D; Palma J; Gaughan JP; Macha M
    Biomed Pharmacother; 2009 Jun; 63(5):331-6. PubMed ID: 18801641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCARD-mediated gene transfer of GRK2 inhibitor in ovine model of acute myocardial infarction.
    Swain JD; Fargnoli AS; Katz MG; Tomasulo CE; Sumaroka M; Richardville KC; Koch WJ; Rabinowitz JE; Bridges CR
    J Cardiovasc Transl Res; 2013 Apr; 6(2):253-62. PubMed ID: 23208013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure.
    Harding VB; Jones LR; Lefkowitz RJ; Koch WJ; Rockman HA
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5809-14. PubMed ID: 11331748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
    Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
    J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.